about
Fourteen years' follow-up of an autoimmune patient lacking the CD3 gamma subunit of the T-lymphocyte receptorAssessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection.Effect of the different 13-valent pneumococcal conjugate vaccination uptakes on the invasive pneumococcal disease in children: Analysis of a hospital-based and population-based surveillance study in Madrid, Spain, 2007-2015.A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome.Expansion of serotype coverage in the universal pediatric vaccination calendar: short-term effects on age- and serotype-dependent incidence of invasive pneumococcal clinical presentations in Madrid, Spain.Impact of introduction of conjugate vaccines in the vaccination schedule on the incidence of pediatric invasive pneumococcal disease requiring hospitalization in Madrid 2007 to 2011.Laboratory-based, 2-year surveillance of pediatric parapneumonic pneumococcal empyema following heptavalent pneumococcal conjugate vaccine universal vaccination in Madrid.Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children.Acquired Senescent T-Cell Phenotype Correlates with Clinical Severity in GATA Binding Protein 2-Deficient Patients.[Abdominal acute pain as initial symptom of invasive meningococcus serogroup A illness].Influenza-related hospitalizations in children younger than three years of age.Sepsis in children with human immunodeficiency virus infection. The Madrid HIV Pediatric Infection Collaborative Study Group.Pediatric Extrapulmonary Tuberculosis: Clinical Spectrum, Risk Factors and Diagnostic Challenges in a Low Prevalence Region.Fatal Mycobacterium avium complex disease in a patient with acute nonlymphoblastic leukemia.Hemophagocytic lymphohistiocytosis in children with visceral leishmaniasis.Decreased activation-induced cell death by EBV-transformed B-cells from a patient with autoimmune lymphoproliferative syndrome caused by a novel FASLG mutation.Lichtheimia corymbifera subcutaneous infection successfully treated with amphotericin B, early debridement, and vacuum-assisted closure.[Successful treatment of catheter-associated candidemia without removing the central venous line].Chagas disease travels to Europe.Epidemiology and economic impact of varicella in immunocompetent children in Spain. A nation-wide study.Severe hypokalemia and rhabdomyolysis associated with itraconazole therapy.Campylobacter sepsis in human immunodeficiency virus-infected children. The Madrid HIV Pediatric Infection Collaborative Study Group.Internationally adopted children: what vaccines should they receive?Outpatient treatment with corticosteroids and antibiotics for acalculous cholecystitis in chronic granulomatous disease.A Scoring System to Predict the Severity of Hirschsprung Disease at Diagnosis and Its Correlation With Molecular Genetics.Use of combined transmucosal fentanyl, nitrous oxide, and hematoma block for fracture reduction in a pediatric emergency department.[Respiratory syncitial virus in immunocompromised patients in a pediatric hospital: 5 years experience].[Guidelines for the treatment of Invasive Candidiasis and other yeasts. Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC). 2010 Update].[Seasonal influenza vaccination in children and adolescents. Recommendations of the CAV-AEP for the campaign].[The Spanish Society of Paediatric Infectious Diseases (SEIP) recommendations on the diagnosis and management of invasive candidiasis].Longitudinal analysis of immune function in the first 3 years of life in thymectomized neonates during cardiac surgery.[Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine].[Family impact of rotavirus gastroenteritis in children under two years].A case of partial dedicator of cytokinesis 8 deficiency with altered effector phenotype and impaired CD8⁺ and natural killer cell cytotoxicity.Invasive antibiotic-resistant Streptococcus pneumoniae in children in Madrid.[2017 pneumococcal vaccine recommendations of the Spanish Association of Paediatrics. Authors reply].The effects on infants of potent antiretroviral therapy during pregnancy: a report from SpainMarcadores predictivos de progresión a sida en niños infectados por transmisión vertical por el virus de la inmunodeficiencia humana tipo 1Immunogenicity and reactogenicity of a booster dose of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroup C-tetanus toxoid conjugate vaccine given to toddlers of 13-14 months of age with antibody persistence up to 31 montLupus like lesions in a patient with X-linked chronic granulomatous disease and recombinant X chromosome
P50
Q24290844-C9232CC6-6098-4311-B565-36D0B5B1564BQ33593822-E9829083-2324-4F7E-B3D6-10C00D0618ECQ36283007-7111D530-076D-4007-913B-3FC6FC52BAB0Q36454970-EB51EFF2-1F98-4962-B0F7-2E5B3E220B52Q38425055-A6432B81-98BB-44AA-8979-F20564F28CE8Q38428544-88DC810B-0CBE-4F53-9791-0CB8C4D68A74Q38440678-20460FCE-8789-4BD5-A706-3399FBAB8793Q38677563-BE442A00-B187-43B0-97DA-FF339ABFCB9AQ40106850-F00A53CD-7D76-47D6-AEA6-9D3785590AA3Q40328698-6E8DA729-F4AF-4073-9C9B-8B440DE4CCE3Q40475797-7C4016F8-CCA5-4CCA-BCE4-4AF489074C28Q40477922-4608CB1A-6936-4F1F-B341-3A7E94A71B9FQ40535399-E027837A-C4EC-4509-8DA5-C0524BC78C9BQ40668763-FE9EB48E-FEE1-4E5A-98E3-1C5FAC456137Q41235345-9B0137B9-C9B5-4EAD-AADB-33D7F3593A40Q41428240-49BFB926-C196-4C08-BFB6-C823830D0580Q42786351-0B15CAF9-1F16-4D7D-AEBB-0675B2DCBEBAQ43185502-AAA94370-8FB9-40D5-89B4-53363A0E505DQ44188434-24952E0E-29AD-46FE-B177-C8E33C604D57Q44476920-C328665B-1677-449B-8F41-D4CBDD6E9D64Q44662727-249DAC52-A1ED-4A4D-AC5F-64C2775D1A81Q45764598-E6A35986-F660-4CF7-A388-FCCE945EF68CQ46186043-E7F21842-8B63-404E-9843-501C4D6D8DD1Q46816615-BE986C70-BF88-4E25-9CE7-75CECBF5F896Q47937886-30E609B9-756B-4365-BC06-0FBA4A7B1BAAQ48151271-9951DD75-A7B7-455D-8738-B7BAE478B2BBQ50282915-2C3323D1-D6DF-49CB-9532-12DF9847C716Q50541087-F334A096-FC64-430A-ABFB-0ABFE95F66BAQ51174287-B57A2C15-A496-4EF7-9287-CB17449381E7Q51175785-142458CF-64A1-4163-99E3-DC48C28E66C8Q51961817-FBAE05B2-32EE-43D3-BC66-81180F5861D7Q52015051-E100C65B-806C-4912-9A25-7B4F6280D92FQ52591259-F76D5239-4457-4A78-92F1-E023116E9D5AQ53062080-B04EC790-1FF9-472F-B280-A33372A219D9Q54142465-17E7C989-CA35-4A3B-87D3-685E3E8A06A1Q54404969-DBB61D1C-C1F1-4D9C-AD65-C32FFAB0B543Q57080044-3B04A1BB-A671-49DD-9ECD-5377966EF1C7Q57080094-3C91C3DB-627C-48CE-A0CB-7966CBEF20B7Q57215945-B7B06621-4B22-488D-B890-87C655CB0EB2Q57649654-0AF5BD3E-0AA7-48DC-8CFD-64ED3BD60B5E
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-2788-7524
@en
name
Jesus Ruiz-Contreras
@ast
Jesus Ruiz-Contreras
@en
Jesus Ruiz-Contreras
@es
Jesus Ruiz-Contreras
@nl
type
label
Jesus Ruiz-Contreras
@ast
Jesus Ruiz-Contreras
@en
Jesus Ruiz-Contreras
@es
Jesus Ruiz-Contreras
@nl
prefLabel
Jesus Ruiz-Contreras
@ast
Jesus Ruiz-Contreras
@en
Jesus Ruiz-Contreras
@es
Jesus Ruiz-Contreras
@nl
P106
P21
P31
P496
0000-0002-2788-7524